These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 21094046)
1. Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor. Yao Z; Xu Y; Zhang M; Jiang S; Nicklaus MC; Liao C Bioorg Med Chem Lett; 2011 Jan; 21(1):475-8. PubMed ID: 21094046 [TBL] [Abstract][Full Text] [Related]
2. Comparative study of human steroid 5alpha-reductase isoforms in prostate and female breast skin tissues: sensitivity to inhibition by finasteride and epristeride. Ranjan M; Diffley P; Stephen G; Price D; Walton TJ; Newton RP Life Sci; 2002 May; 71(2):115-26. PubMed ID: 12031682 [TBL] [Abstract][Full Text] [Related]
3. Effects of competitive and noncompetitive 5α-reductase inhibitors on serum and intra-prostatic androgens in beagle dogs. Zhao XF; Yang Y; Wang W; Qiu Z; Zhang P; Wang B Chin Med J (Engl); 2013 Feb; 126(4):711-5. PubMed ID: 23422194 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and bioactivity of new Finasteride conjugate. Shuang Z; Jiazhen W; Lijuan Y; Zhuo L; Dahai Y; Jinfeng L; Jing Y; Yongtao L; En-Si W; Xuexun F Bioorg Med Chem Lett; 2011 Jun; 21(11):3439-42. PubMed ID: 21515045 [TBL] [Abstract][Full Text] [Related]
5. Potency of a novel saw palmetto ethanol extract, SPET-085, for inhibition of 5alpha-reductase II. Pais P Adv Ther; 2010 Aug; 27(8):555-63. PubMed ID: 20623347 [TBL] [Abstract][Full Text] [Related]
6. A review on steroidal 5α-reductase inhibitors for treatment of benign prostatic hyperplasia. Sun J; Xiang H; Yang LL; Chen JB Curr Med Chem; 2011; 18(23):3576-89. PubMed ID: 21756226 [TBL] [Abstract][Full Text] [Related]
7. CGP 53153: a new potent inhibitor of 5alpha-reductase. Häusler A; Allegrini PR; Biollaz M; Batzl C; Scheidegger E; Bhatnagar AS J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):187-95. PubMed ID: 8645628 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel 3-oxo-4-oxa-5α-androst-17β-amide derivatives as dual 5α-reductase inhibitors and androgen receptor antagonists. Lao K; Sun J; Wang C; Wang Y; You Q; Xiao H; Xiang H Bioorg Med Chem Lett; 2017 Sep; 27(17):4212-4217. PubMed ID: 28757062 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and 5α-reductase inhibitory activity of C₂₁ steroids having 1,4-diene or 4,6-diene 20-ones and 4-azasteroid 20-oximes. Kim S; Kim YU; Ma E Molecules; 2011 Dec; 17(1):355-68. PubMed ID: 22210173 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic parameters and mechanisms of inhibition of rat type 1 and 2 steroid 5alpha-reductases: determinants for different in vivo activities of GI198745 and finasteride in the rat. Stuart JD; Lee FW; Simpson Noel D; Kadwell SH; Overton LK; Hoffman CR; Kost TA; Tippin TK; Yeager RL; Batchelor KW; Bramson HN Biochem Pharmacol; 2001 Oct; 62(7):933-42. PubMed ID: 11543729 [TBL] [Abstract][Full Text] [Related]
11. The effects of progesterone, 4,16-androstadien-3-one and MK-434 on the kinetics of pig testis microsomal testosterone-4-ene-5alpha-reductase activity. Cooke GM; Pothier F; Murphy BD J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):353-9. PubMed ID: 9219928 [TBL] [Abstract][Full Text] [Related]
12. Steroidal pyrazolines and pyrazoles as potential 5α-reductase inhibitors: synthesis and biological evaluation. Banday AH; Shameem SA; Jeelani S Steroids; 2014 Dec; 92():13-9. PubMed ID: 25278254 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel androst-3,5-diene-3-carboxylic acid derivatives as inhibitors of 5α-reductase type 1 and 2. Lao K; Sun J; Wang C; Lyu W; Zhou B; Zhao R; Xu Q; You Q; Xiang H Steroids; 2017 Aug; 124():29-34. PubMed ID: 28549802 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, Biological Evaluation and Molecular Docking of Avicequinone C Analogues as Potential Steroid 5α-Reductase Inhibitors. Karnsomwan W; Netcharoensirisuk P; Rungrotmongkol T; De-Eknamkul W; Chamni S Chem Pharm Bull (Tokyo); 2017; 65(3):253-260. PubMed ID: 28250347 [TBL] [Abstract][Full Text] [Related]
15. Steroid 5α-reductase as a novel therapeutic target for schizophrenia and other neuropsychiatric disorders. Paba S; Frau R; Godar SC; Devoto P; Marrosu F; Bortolato M Curr Pharm Des; 2011; 17(2):151-67. PubMed ID: 21361868 [TBL] [Abstract][Full Text] [Related]
16. Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target. Giatti S; Di Domizio A; Diviccaro S; Falvo E; Caruso D; Contini A; Melcangi RC J Med Chem; 2021 Apr; 64(8):4553-4566. PubMed ID: 33843213 [TBL] [Abstract][Full Text] [Related]
17. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia. Bartsch G; Rittmaster RS; Klocker H Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065 [TBL] [Abstract][Full Text] [Related]
18. Finasteride is the main inhibitor of 5alpha-reductase activity in microdissected dermal papillae of human hair follicles. Hoffmann R; Happle R Arch Dermatol Res; 1999; 291(2-3):100-3. PubMed ID: 10195397 [No Abstract] [Full Text] [Related]
19. Structure of human steroid 5α-reductase 2 with the anti-androgen drug finasteride. Xiao Q; Wang L; Supekar S; Shen T; Liu H; Ye F; Huang J; Fan H; Wei Z; Zhang C Nat Commun; 2020 Oct; 11(1):5430. PubMed ID: 33110062 [TBL] [Abstract][Full Text] [Related]
20. Effect of a novel steroid (PM-9) on the inhibition of 5alpha-reductase present in Penicillium crustosum broths. Flores E; Cabeza M; Quiroz A; Bratoeff E; García G; Ramírez E Steroids; 2003 Mar; 68(3):271-5. PubMed ID: 12628690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]